Thomas Hofmann
Chief Executive Officer at Aumapharma, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sabrina Kay | M | 61 | 4 years | |
| Lauren Sabella | F | 63 | 1 years | |
| Burkhard Blank | M | 69 | 1 years | |
| David Thomson | M | 57 |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | - |
| Gregor Schulz | M | 74 |
University of Giessen
| 32 years |
| Sanjay Singh | M | 57 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christian Pangratz | M | - |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | 3 years |
| Christian Gebauer-Rochholz | M | 58 |
University of Giessen
| 3 years |
| John Stuart Patton | M | 77 |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | 7 years |
| Susanne Fuchs | M | 60 |
University of Giessen
| 3 years |
| Markus H. Thoma | M | 66 |
University of Giessen
| 4 years |
| Ingo Weber | M | - |
University of Giessen
| 4 years |
| Ralf Guckert | M | 58 |
University of Giessen
| 6 years |
| Stefan Thies | M | - |
University of Giessen
| 5 years |
| Stefan Degenhardt | M | - |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | - |
| Joachim Gläser | M | 56 |
University of Giessen
| 3 years |
| Jörg Neermann | M | 57 |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | - |
| Steffen Suhany | M | - |
University of Giessen
| 4 years |
| Alejandro Galindo | M | 51 | 2 years | |
| Holger Kowarsch | M | 55 |
University of Giessen
| 6 years |
| Robert Latka | M | 58 |
University of Giessen
| 4 years |
| Ulrich Dauer | M | 59 |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | - |
| Frank Alexander Rothauge | M | 55 |
University of Giessen
| 5 years |
| Florian Fischer | M | 56 |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | 9 years |
| Petra Goessens-Rueck | M | - |
University of Giessen
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 19 | 76.00% |
| United States | 6 | 24.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Hofmann
- Personal Network